Empagliflozin as a new management strategy on outcomes in patients with type 2 diabetes mellitus

Patients with type 2 diabetes mellitus have an increased risk of cardiovascular (CV) complications. Although hyperglycaemia contributes to the pathogenesis of atherosclerosis and heart failure in these patients, glucose-lowering strategies did not have a significant effect on reducing CV risk, parti...

Full description

Saved in:
Bibliographic Details
Main Authors: Vladimir V. Salukhov, Tatiana Y. Demidova
Format: Article
Language:English
Published: Endocrinology Research Centre 2016-12-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/8216
Tags: Add Tag
No Tags, Be the first to tag this record!